Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2006-09-19

Clinical Trial Update: Aurograb and Vancomycin in MRSA Infection [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Aurograb with vancomycin for MRSA-related staphylococcal infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aurograb
  • Vancomycin (vancomycin)

Snippet

Sponsor: NeuTec Pharma | Conditions: Staphylococcal Infections | Phase 3 | Status: COMPLETED